BlaidsX Micro vs MDHearing Volt

The BlaidsX Micro is a budget-priced OTC hearing aid that earned a B grade with a SoundScore of 3.0/5 in HearAdvisor's lab testing. At $499, it sits in the entry-level price tier but ranks #59 of 65 OTC hearing aids tested, placing it in the bottom portion of its category. In our testing, the BlaidsX Micro delivered mixed results across key performance areas. Its standout strength is excellent feedback handling, scoring a perfect 5.0/5 after tuning—0.46 points above the category average. This means users are unlikely to experience whistling or squealing during normal use. Speech in quiet environments scored 2.9/5, which is above the category average by 0.09 points, though this remains a mixed absolute score. The device shows notable weaknesses in several areas. Speech in noise performance is low at 1.0/5, falling 0.48 points below the OTC category average. Own-voice comfort also scored low at 1.0/5, sitting 1.51 points below average—users may notice their own voice sounds boomy or unnatural. Music streaming is not a viable use case with this device, scoring 0.0/5, which is 1.92 points below the category average. Budget-conscious shoppers should note that several competitors in the same price range offer significantly better overall performance, including the Elehear Beyond (4.34/5) and Apple AirPods Pro 2 (4.04/5). The BlaidsX Micro may suit buyers primarily concerned with feedback-free amplification in quiet settings, but those needing help in noisy environments or who want streaming capabilities should consider alternatives.

The MDHearing Volt is a budget-priced prescription hearing aid released in 2020, earning a B grade with a SoundScore of 3.0/5 in our lab testing. At $397, it sits in the lowest price tier for prescription devices, ranking #34 of 39 in its category. In our testing, the Volt showed a mixed performance profile with one standout strength: feedback handling scored an excellent 5.0/5, which is 0.28 points above the category average. This means users can expect minimal whistling or squealing during typical wear. However, speech performance was limited, with speech in quiet scoring 1.8/5 (1.65 points below average) and speech in noise at 1.0/5 (1.11 points below average). Own voice comfort was mixed at 2.6/5, roughly matching the category average. Music streaming capability was not functional in our testing, scoring 0.0/5—a significant limitation for users who want to stream audio from their phone. This is 2.76 points below the prescription hearing aid category average. The Volt may appeal to budget-conscious consumers who prioritize basic amplification and feedback-free wear over advanced speech enhancement or streaming features. Those seeking stronger speech performance in the same price range may want to consider alternatives like the RxEars Rxi, which scored 4.07/5 in our testing. The Volt's rechargeable battery and behind-the-ear design offer practical convenience, but its core sound performance reflects its entry-level positioning.